For investors seeking momentum, Columbia India Small Cap ETF is probably on radar now. The fund just hit a 52-week high and is up over 37% from its 52-week low price of $12.84/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
SCIN in Focus
This product offers exposure to the small-cap stocks of India. Banks, Construction & Engineering and Pharmaceuticals are the top three sectors of the fund. The fund charges 86 bps in fees (see all Asia-Pacific (Emerging) ETFs here).
Why the Move?
Indian stocks are rallying on the ruling central government’s election victory in some key states. Notably, the government is viewed as pro-growth. Plus, India came up with upbeat GDP growth data of 7% in the October–December quarter despite demonetarization. The expansion breezed past economists’ expectations of 6.4%. Such upbeat sentiments were enough to spur investors’ optimism in small-cap stocks as capitalization better reflects the domestic economy.
More Gains Ahead?
The fund has a Zacks ETF Rank #2 (Buy) with a high risk outlook. Plus, the fund has a positive weighted alpha of 34.90. A positive weighted alpha hints at more gains. As a result, there is definitely still some promise for investors who want to ride on this surging ETF.
Want key ETF info delivered straight to your inbox?
Zacks' free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
For investors seeking momentum, Columbia India Small Cap ETF is probably on radar now. The fund just hit a 52-week high and is up over 37% from its 52-week low price of $12.84/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
SCIN in Focus
This product offers exposure to the small-cap stocks of India. Banks, Construction & Engineering and Pharmaceuticals are the top three sectors of the fund. The fund charges 86 bps in fees (see all Asia-Pacific (Emerging) ETFs here).
Why the Move?
Indian stocks are rallying on the ruling central government’s election victory in some key states. Notably, the government is viewed as pro-growth. Plus, India came up with upbeat GDP growth data of 7% in the October–December quarter despite demonetarization. The expansion breezed past economists’ expectations of 6.4%. Such upbeat sentiments were enough to spur investors’ optimism in small-cap stocks as capitalization better reflects the domestic economy.
More Gains Ahead?
The fund has a Zacks ETF Rank #2 (Buy) with a high risk outlook. Plus, the fund has a positive weighted alpha of 34.90. A positive weighted alpha hints at more gains. As a result, there is definitely still some promise for investors who want to ride on this surging ETF.
Want key ETF info delivered straight to your inbox?
Zacks' free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>